MOSCOW, Oct 29 (NNN-AGENCIES) — The Russian Direct Investment Fund (RDIF) has submitted applications to the World Health Organization for an Emergency Use Listing and prequalification of its COVID-19 vaccine, Sputnik V, Russia’s sovereign wealth fund said.
Russia was the first country to grant regulatory approval for a novel coronavirus vaccine, and did so before large-scale trials were complete, stirring concerns among scientists and doctors about the safety and efficacy of the shot.
An Emergency Use Listing (EUL) is meant to make a vaccine available globally faster, while a WHO prequalification is a global quality tag that ensures vaccines are safe and effective.
The procedures would allow Sputnik V to be included in the list of medical products that meet leading quality, safety and efficacy standards, RDIF CEO Kirill Dmitriev said in a statement.
The vaccine, developed by Moscow’s Gamaleya Research Institute and marketed by RDIF, is based on a platform of human adenoviral vectors. — NNN-AGENCIES
